Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion type Assertion NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_head.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion description "[The aggregate frequency of CHD5 haploinsufficiency or inactivation is 16.2% in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_provenance.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion evidence source_evidence_literature NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_provenance.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion SIO_000772 18953434 NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_provenance.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion wasDerivedFrom befree-20140225 NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_provenance.
- NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_assertion wasGeneratedBy ECO_0000203 NP322735.RAoS43ULuZtXNHM-3Bmn8_aB2Pdv1MvqwWCq3kxhnuV_0130_provenance.